semaglutide and cagrilintide Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study GLP-1 (S) + Cagrilintide -

Behind the two market leaders are a wave of new entrants hoping to get into the massive market in the coming years

demonstrated that combined GHRH + GHRP administration produced 2 to 3 times more GH release than either compound individually in healthy subjects (Anderson et al., J Clin Endocrinol Metab 2001)

Back Molteni, M (17 Oct 2023) 'How one scientist's determination made Novo Nordisk an obesity-drug powerhouse', STAT News

This underscores the role of nanomedicine in enhancing the anti-tumor bioactivity and bioavailability of green tea polyphenols (142)

For patients with pre-existing hypertension taking antihypertensive medications, semaglutide-associated weight loss may necessitate medication adjustments